Related Experiment Videos
[Metallothionein and cancer]
Wei Sheng Yan Jiu = Journal of Hygiene Research
|April 26, 2003
Summary
Metallothionein (MT) proteins may reduce anticancer drug side effects and impact cancer development and resistance. Further research explores MT's role in cancer therapy and drug resistance.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Context:
- Metallothioneins (MTs) are cysteine-rich, low-molecular-weight proteins.
- Emerging evidence suggests MTs are involved in carcinogenesis and cancer treatment.
Purpose:
- To investigate the role of MT in mitigating anticancer drug toxicity.
- To explore the potential involvement of MT in cancer initiation.
- To examine the relationship between MT expression and tumor cell resistance to chemotherapy.
Summary:
- This research reviews the multifaceted roles of metallothioneins (MTs).
- It examines MTs' potential to alleviate side effects from anticancer drugs.
- The study also investigates MTs' involvement in cancer development and acquired resistance in tumor cells.
Impact:
- Understanding MTs' functions can lead to improved cancer therapy strategies.
- This knowledge may help in developing methods to overcome drug resistance in cancer patients.
- MTs could be potential biomarkers for cancer prognosis and therapeutic response.